Catalyst Wire Dossier Catalyst Wire Dossier

ARO-C3

· Arrowhead Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARO-C3, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease [Phase 1, Phase 2]

See pricing